Loading...

Hansoh Pharmaceutical Group Company Limited

3692.HKHKSE
Healthcare
Drug Manufacturers - Specialty & Generic
HK$29.75
HK$0.65(2.23%)

Hansoh Pharmaceutical Group Company Limited 3692.HK Peers

See (3692.HK) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
3692.HKHK$29.75+2.23%176.9B37.19HK$0.80N/A
2196.HKHK$16.88+4.07%68.3B14.07HK$1.20+1.78%
0874.HKHK$17.40+0.00%43.8B9.61HK$1.81+5.05%
1513.HKHK$29.55+0.68%32.8B11.73HK$2.52+4.06%
3320.HKHK$5.12-1.35%32.2B8.83HK$0.58+2.87%
0512.HKHK$8.72+1.04%30.5B12.46HK$0.70+2.98%
0867.HKHK$12.00+0.00%29B16.44HK$0.73+2.43%
3933.HKHK$15.02+1.08%27.3B9.39HK$1.60+4.10%
0013.HKHK$23.55-0.84%20.5B75.97HK$0.31N/A
9989.HKHK$5.33+1.14%17.3B11.10HK$0.48+40.01%
Showing 1 to 10 of 42 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

3692.HK vs 2196.HK Comparison

3692.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3692.HK stands at 176.9B. In comparison, 2196.HK has a market cap of 68.3B. Regarding current trading prices, 3692.HK is priced at HK$29.75, while 2196.HK trades at HK$16.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3692.HK currently has a P/E ratio of 37.19, whereas 2196.HK's P/E ratio is 14.07. In terms of profitability, 3692.HK's ROE is +0.15%, compared to 2196.HK's ROE of +0.06%. Regarding short-term risk, 3692.HK is less volatile compared to 2196.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3692.HK.

Stock Price Comparison

Loading...

Frequently Asked Questions

;